Indicators

Markets:

News

Latest News about Biogen Inc

Recent news which mentions Biogen Inc

< Previous 1 2 3 4 Next >

Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug

August 07, 2023

Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more

July 28, 2023

Stocks making the biggest moves midday: Spotify, RTX, General Electric and more

July 25, 2023

Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch

July 25, 2023

5 things to know before the stock market opens Tuesday

July 18, 2023

Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year

July 17, 2023

Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know

July 08, 2023

Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024

July 07, 2023

Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more

July 07, 2023

Stocks making the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more

July 07, 2023

Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug

July 07, 2023

FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage

July 06, 2023

Stocks making the biggest moves midday: JD.Com, Biogen, Oracle and more

June 13, 2023

FDA advisors to weigh whether Alzheimer's drug Leqembi should receive full approval

June 09, 2023

Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action

June 07, 2023

Jim Cramer expects defensive stocks to be resilient as debt ceiling talks drag on

May 15, 2023

Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates

May 12, 2023

Stocks making the biggest moves premarket: Starbucks, AMD, Pearson, PacWest & more

May 03, 2023

Bipartisan attorneys general call on Medicare to cover Alzheimer's treatments

May 01, 2023

Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease

April 30, 2023

Alzheimer's: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says

April 26, 2023

Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says

April 25, 2023

FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease

April 25, 2023

Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says

April 06, 2023

Eli Lilly says experimental Alzheimer's drug reduces brain plaque in early study

April 05, 2023

FDA advisors reject Biogen's ALS drug for rare and aggressive form of the disease

March 22, 2023

FDA staff says Biogen's ALS drug may have a 'clinical benefit' on a rare form of the disease

March 20, 2023

Veterans' Health will cover Alzheimer's treatment Leqembi for some patients

March 13, 2023

FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July

March 06, 2023

Medicare rejects Alzheimer's Association request for unrestricted coverage of treatments like Leqembi

February 23, 2023

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.